Merck & Co. (MSD)

As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals Fierce Pharma

Merck and Gilead discontinue Phase III KEYNOTE-D46/EVOKE-03 study The Pharma Letter

Major US Pharma and Biotech Deals of the Past Decade Global Banking & Finance Review

Major deals involving US drugmakers and biotechs over the past decade Reuters

Gilead's lung cancer bid for Trodelvy hits wall, but HIV studies deliver better news FirstWord Pharma

Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise (NYSE:MRK) Seeking Alpha